One-Year DA VINCI Outcomes Show Sustained Efficacy, Safety For Anti-VEGF | OphthalmologyWeb: The Ultimate Online Resource for Ophthalmologists

Wednesday, January 25, 2012

Ocular Surgery News

Clinical results through 52 weeks suggest sustained efficacy and safety for aflibercept in treating diabetic macular edema, a speaker here said.

Which of the following is NOT a typical sign of thyroid eye disease?
1. proptosis
2. ptosis
3. lid retraction
4. lid lag
Check The Answer

Smartphone-Based Retinal Screening System
D-EYE, The Modern Day Digital ... view product
OPMI LUMERA 700 Surgical Microscope
OPMI LUMERA 700 Incorporating the latest... view product

View all Featured Products »

Keep up with our latest articles, news and events. Plus, get special offers and more delivered to your inbox.

Like us
on Facebook Follow us
on Twitter

OphthalmologyWeb wants to hear from you. Submit your case studies, clinical pearls, practice management tips, editorial, or other manuscripts.

Learn more about writing for us